Related Experiment Video
Updated: Sep 25, 2026

Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice
Published on: September 8, 2011
A method using L-hyoscyamine for the study of muscarinic acetylcholine receptor binding in vivo
Abstract:
Studies of muscarinic receptor concentration and comparative binding assays of agonists and antagonists are presently done in vitro by incubation and measurement of the binding to tissue homogenates of the radiolabelled potent antagonists 3H-scopolamine or 3H-quinuclidinyl benzilate. We have developed a technique based on gas chromatography-mass spectrometry that allows studies of the muscarinic receptor concentration to be performed in vivo under physiologic conditions. By injecting the optical antipodes of atropine, D- and L-hyoscyamine separately in mice and following their kinetics in different parts of the brain it was possible to separate the specific receptor binding of the active antipode L-hyoscyamine from that of the inactive antipode D-hyoscyamine, representing unspecific binding. Two hrs after the administration of L-hyoscyamine, 2 mg/kg intravenously, its concentration in brain was found to represent "maximum" specific binding. The physiological significance of specifically bound L-hyoscyamine was tested on its blocking effect on oxotremorine induced tremor.
More Related Videos
Related Concept Videos
Cholinergic Receptors: Muscarinic
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

